Report Description

Needle-free drug delivery devices are novel techniques to introduce drugs into patient’s body without invading the skin with a conventional needle. This technology provides effective drug delivery for wide range of drugs; it is bioequivalent to syringe and needle and results in less pain. Needle-Free Drug Delivery market report studies the current scenario as well as the future market potential for needle-free drug delivery devices globally. The needle-free drug delivery devices market has been segmented in two major segments, on the basis of technology and applications. Needle-free drug delivery devices market by technology is sub segmented as jet injectors and competing needle-free technologies. Further, competing needle-free technologies are divided into novel needle technology, inhaler technology and transdermal patch delivery. The market size and forecasts in terms of revenue (USD million) for each of these segments have been provided for the period 2011 to 2019, considering 2012 as the base year. The market for these technologies has been extensively analyzed on the basis of factors such as technology, durability, value, user preference, regulatory norms and others. The needle-free drug delivery devices market report also provides the compounded annual growth rate (CAGR) for each segment of the market for the forecast period 2013 to 2019.
Needle-free drug delivery device market by applications is further segmented as, vaccine delivery (developing immune response), pain management, insulin delivery for diabetes, pediatric injections and other classes. The market for these applications has been extensively analyzed on the basis of factors such as patient compliance and acceptability, increased utility of needle-free devices in various kinds of diseases, opportunities for the development of home-care and self medication devices and others.

Complete Report with TOC @ http://www.mrrse.com/needle-free-delivery-devices-market

Scope

North America accounted for the largest share of the global needle-free drug delivery devices market. This growth was mainly attributed to rising public awareness against novel drug delivery systems, increasing government initiatives for introduction of needle-free drug delivery devices in community vaccination programs, growing home healthcare and key players domiciled in this region. Asia-Pacific region is expected to grow at the highest CAGR during the forecast period from 2013 to 2019 owing to rising prevalence of diabetes and increasing healthcare awareness in this region.

Key Players

Antares Pharma, Inc., Glide Pharmaceutical Technologies Ltd., 3M, Zogenix and Ypsomed Holding AG are some of the key players having presence in the global needle-free drug delivery devices market.

Request a Sample Copy of the Report @ http://www.mrrse.com/sample/1185

About MRRSE

MRRSE stands for Market Research Reports Search Engine, the largest online catalog of latest market research reports based on industries, companies, and countries. MRRSE sources thousands of industry reports, market statistics, and company profiles from trusted entities and makes them available at a click. Besides well-known private publishers, the reports featured on MRRSE typically come from national statistics agencies, investment agencies, leading media houses, trade unions, governments, and embassies.

Contact
Corporate Office
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States

Tel: +1-518-618-1030
Email: [email protected]